Literature DB >> 34279571

In silico model for miRNA-mediated regulatory network in cancer.

Khandakar Tanvir Ahmed1, Jiao Sun1, William Chen1, Irene Martinez2, Sze Cheng3, Wencai Zhang4, Jeongsik Yong3, Wei Zhang1.   

Abstract

Deregulation of gene expression is associated with the pathogenesis of numerous human diseases including cancer. Current data analyses on gene expression are mostly focused on differential gene/transcript expression in big data-driven studies. However, a poor connection to the proteome changes is a widespread problem in current data analyses. This is partly due to the complexity of gene regulatory pathways at the post-transcriptional level. In this study, we overcome these limitations and introduce a graph-based learning model, PTNet, which simulates the microRNAs (miRNAs) that regulate gene expression post-transcriptionally in silico. Our model does not require large-scale proteomics studies to measure the protein expression and can successfully predict the protein levels by considering the miRNA-mRNA interaction network, the mRNA expression, and the miRNA expression. Large-scale experiments on simulations and real cancer high-throughput datasets using PTNet validated that (i) the miRNA-mediated interaction network affects the abundance of corresponding proteins and (ii) the predicted protein expression has a higher correlation with the proteomics data (ground-truth) than the mRNA expression data. The classification performance also shows that the predicted protein expression has an improved prediction power on cancer outcomes compared to the prediction done by the mRNA expression data only or considering both mRNA and miRNA. Availability: PTNet toolbox is available at http://github.com/CompbioLabUCF/PTNet.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  3’-UTR APA; graph-based learning model; miRNA regulation; protein expression prediction

Mesh:

Substances:

Year:  2021        PMID: 34279571      PMCID: PMC8575005          DOI: 10.1093/bib/bbab264

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   13.994


  90 in total

1.  An integrative model for alternative polyadenylation, IntMAP, delineates mTOR-modulated endoplasmic reticulum stress response.

Authors:  Jae-Woong Chang; Wei Zhang; Hsin-Sung Yeh; Meeyeon Park; Chengguo Yao; Yongsheng Shi; Rui Kuang; Jeongsik Yong
Journal:  Nucleic Acids Res       Date:  2018-07-06       Impact factor: 16.971

2.  A genetic variant located in miR-423 is associated with reduced breast cancer risk.

Authors:  Robert A Smith; Dominik J Jedlinski; Plamena N Gabrovska; Stephen R Weinstein; Larisa Haupt; Lyn R Griffiths
Journal:  Cancer Genomics Proteomics       Date:  2012 May-Jun       Impact factor: 4.069

3.  Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

Authors:  Nerea Matamala; María Teresa Vargas; Ricardo González-Cámpora; Rebeca Miñambres; José Ignacio Arias; Primitiva Menéndez; Eduardo Andrés-León; Gonzalo Gómez-López; Kira Yanowsky; Julio Calvete-Candenas; Lucía Inglada-Pérez; Beatriz Martínez-Delgado; Javier Benítez
Journal:  Clin Chem       Date:  2015-06-08       Impact factor: 8.327

4.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

5.  MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.

Authors:  Tyler E Miller; Kalpana Ghoshal; Bhuvaneswari Ramaswamy; Satavisha Roy; Jharna Datta; Charles L Shapiro; Samson Jacob; Sarmila Majumder
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

6.  miRDB: an online resource for microRNA target prediction and functional annotations.

Authors:  Nathan Wong; Xiaowei Wang
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 16.971

7.  MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer.

Authors:  Y Lu; T Qin; J Li; L Wang; Q Zhang; Z Jiang; J Mao
Journal:  Cancer Gene Ther       Date:  2017-07-28       Impact factor: 5.987

8.  Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer.

Authors:  Yuhong Sun; Xuefei Bao; Yong Ren; Lina Jia; Shenglan Zou; Jian Han; Mengyue Zhao; Mei Han; Hong Li; Qixiang Hua; Yi Fang; Jingyu Yang; Chunfu Wu; Guoliang Chen; Lihui Wang
Journal:  Cell Death Dis       Date:  2019-05-24       Impact factor: 8.469

9.  MiR-200c and HuR in ovarian cancer.

Authors:  Silvia Prislei; Enrica Martinelli; Marisa Mariani; Giuseppina Raspaglio; Steven Sieber; Gabriella Ferrandina; Shohreh Shahabi; Giovanni Scambia; Cristiano Ferlini
Journal:  BMC Cancer       Date:  2013-02-08       Impact factor: 4.430

10.  Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.

Authors:  Yong-Wan Kim; Eun Young Kim; Doin Jeon; Juinn-Lin Liu; Helena Suhyun Kim; Jin Woo Choi; Woong Shick Ahn
Journal:  Drug Des Devel Ther       Date:  2014-02-24       Impact factor: 4.162

View more
  1 in total

1.  Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells.

Authors:  Jiao Sun; Naima Ahmed Fahmi; Heba Nassereddeen; Sze Cheng; Irene Martinez; Deliang Fan; Jeongsik Yong; Wei Zhang
Journal:  Int J Mol Sci       Date:  2021-09-07       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.